Biotech Industry Needs 42 Representatives to Try to Refute Jane Hamsher

By: Sunday November 15, 2009 8:33 am

On October 29, Jane wrote a scathing post about what Anna Eshoo’s provision to give biosimilars a route to approval would do, focusing on the 12 years–and probably more–of monopoly it would grant.

The following day–October 30–Eshoo responded.


The Algebra of Need: Cancer, Biologics, PhRMA

By: Friday November 13, 2009 5:12 pm

If you had to choose: four point seven months for your spouse, or four years of college for your child? A monthly bill from the chemotherapy center, or the monthly mortgage?

As someone with recent experience, I can tell you that you would do anything – anything – that held out hope. That the equation of $80,000 for the possibility of 1.2 months would make sense to you.

ACTION: Treat Patients, Not PhRMA Tricks

By: Friday November 6, 2009 3:02 pm

Help Medical Students Fight PhMRA for affordable generics with their POP video: 1) Click here to automatically Tweet about this video 2) Post to your Facebook Page 3) Copy and paste this to your FB status: Beat PhRMA! Votes on health care tomorrow. Watch this video and share: 4) Rate and favorite this video [...]

CA-36: Winograd Takes On Harman over Biologics

By: Friday November 6, 2009 9:44 am

As Jane Hamsher noted today, Marcy Winograd, the progressive challenger to Jane Harman in CA-36, released a letter savaging Harman for her support of the Eshoo amendment on biologics in the Energy and Commerce Committee. Though Congressman Waxman (D-Santa Monica/West LA) had introduced an amendment for a 5-year fast-track of generic biologics, Harman joined with [...]

Marcy Winograd: Jane Harman Profits from Anti-Generics Amendment She Helped Eshoo Pass

By: Friday November 6, 2009 7:18 am

Anna Eshoo (D-PhRMA) may be the author of the language granting drug companies endless monopolies on biologic drugs, but she couldn’t have done it without the help of her good friend Jane Harman. A new letter from the Marcy Winograd campaign says: The latest health insurance reform bill includes an amendment, supported by Jane Harman, [...]

Bipartisanship Lives! Eshoo Amendment Embraced by GOP in “Alternative” Health Bill

By: Tuesday November 3, 2009 11:45 am

The Republican’s have just released their “alternative” bill to the Democrats’ health care reform legislation. It is frankly a meaningless, very long press release, filled with some really bad ideas. The Republicans did find basically only one section of the Democrats’ reform bill they really liked. In fact, the Republicans thought it was such a [...]

Sherrod Brown: Biologics Should Not be Subject to an “Endless Monopoly Period”

By: Monday November 2, 2009 6:30 pm

Sen. Sherrod Brown of Ohio has been the leading voice in the Senate on the issue of biologics, the expensive drug treatments made from living organisms, and his advocacy for affordable, generic versions of the potentially life-saving drugs will continue once the Senate health care bill hits the floor. The Senate HELP Committee version of [...]

So What Does Jay Inslee Think You Deserve For Your Enbrel Investment?

By: Monday November 2, 2009 11:34 am

While I was searching for Henry Waxman’s comments about Anna Eshoo’s PhRMA boondoggle which will leave cancer patients in financial ruin just to pay for lifesaving biologic drugs, I came across a bizarre claim from her cosponsor Jay Inslee. He seems to believe that these companies need to be granted a monopoly on these drugs [...]

Waxman to Eshoo: You’ve Got an “Evergreening Problem”

By: Monday November 2, 2009 8:15 am

In her response to my article on her biologics bill, Anna Eshoo vehemently claims it doesn’t allow “evergreening,” which would allow slight tweaks in drug formulas to grant drug companies endless monopolies and keep these lifesaving drugs from ever becoming generics: There is no ‘evergreening’ clause in my legislation. There is in fact an ‘anti-evergreening’ [...]

Are You or Someone You Know Paying $50,000 a Year for Drugs?

By: Tuesday October 27, 2009 8:01 am

The public option has received the lion’s share of attention in the health care debate, but there is an equally important one relating to generic drugs that could mean the lifesaving drugs of the future remain too expensive for all but the wealthy. Biologics are drugs made from living organisms, and they are considered the [...]

Follow Firedoglake
CSM Ads advertisement